0001209191-18-058051.txt : 20181109
0001209191-18-058051.hdr.sgml : 20181109
20181109200608
ACCESSION NUMBER: 0001209191-18-058051
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181102
FILED AS OF DATE: 20181109
DATE AS OF CHANGE: 20181109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Eric Alejandro
CENTRAL INDEX KEY: 0001758494
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 181174502
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 3611 VALLEY CENTRE DRIVE, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2018-11-02
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001758494
Miller Eric Alejandro
C/O ACADIA PHARMACEUTICALS INC.
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
Controller & PAO
Common Stock
3212
D
Employee Stock Option (Right to Buy)
20.65
2024-05-29
Common Stock
7500
D
Employee Stock Option (Right to Buy)
32.28
2025-01-25
Common Stock
3900
D
Employee Stock Option (Right to Buy)
29.24
2026-01-05
Common Stock
6615
D
Employee Stock Option (Right to Buy)
36.54
2027-03-07
Common Stock
7350
D
Employee Stock Option (Right to Buy)
35.80
2027-09-06
Common Stock
9187
D
Employee Stock Option (Right to Buy)
16.50
2028-04-06
Common Stock
5570
D
Employee Stock Option (Right to Buy)
21.28
2028-10-14
Common Stock
3342
D
Restricted Stock Units
Common Stock
1671
D
This option is fully vested and exercisable.
25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2016, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2017, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the Stock Option vested and became exercisable on March 8, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the Stock Option vest and become exercisable on April 7, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
The restricted stock units vest in four equal annual installments beginning October 15, 2019.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
/s/ Eric Alejandro Miller
2018-11-09
EX-24.3_816575
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby authorizes Austin D.
Kim, Reena Desai or Martin Choy to execute for and on behalf of the undersigned,
in the undersigned's capacity as an officer of ACADIA Pharmaceuticals Inc. (the
"Company"), Forms 3, 4 and 5 and any Amendments thereto, and cause such form(s)
to be filed with the Securities and Exchange Commission pursuant to Section
16(a) of the Securities Exchange Act of 1934, relating to the undersigned's
beneficial ownership of securities in the Company. The undersigned hereby
grants to such attorney-in-fact full power and authority to do and perform any
and every act and thing whatsoever requisite, necessary, or proper to be done in
the exercise of any of the rights and powers herein granted, as fully to all
intents and purposes as the undersigned might or could do if personally present,
with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or substitute or substitutes of such
attorney-in-fact, shall lawfully do or cause to be done by virtue of this power
of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving in such capacity at
the request of the undersigned, is not assuming, nor is the Company assuming,
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 9th day of November 2018.
/s/ Eric Miller